Your browser doesn't support javascript.
Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'.
Zheng, Ying-Ying; Ma, Yi-Tong; Zhang, Jin-Ying; Xie, Xiang.
  • Zheng YY; Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Ma YT; Key Laboratory of Cardiac Injury and Repair of Henan Province, Zhengzhou, China.
  • Zhang JY; Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. myt_xj@sina.com.
  • Xie X; Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. jyzhang@zzu.edu.cn.
Nat Rev Cardiol ; 17(5): 313-314, 2020 05.
Article in English | MEDLINE | ID: covidwho-28970

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Renin-Angiotensin System / Peptidyl-Dipeptidase A / Betacoronavirus Limits: Humans Language: English Journal: Nat Rev Cardiol Journal subject: Cardiology Year: 2020 Document Type: Article Affiliation country: S41569-020-0369-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Renin-Angiotensin System / Peptidyl-Dipeptidase A / Betacoronavirus Limits: Humans Language: English Journal: Nat Rev Cardiol Journal subject: Cardiology Year: 2020 Document Type: Article Affiliation country: S41569-020-0369-9